ALX Oncology’s (ALXO) Buy Rating Reiterated at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of ALX Oncology (NASDAQ:ALXO – Free Report) in a research report report published on Friday,Benzinga reports. HC Wainwright currently has a $5.00 price target on the stock. ALXO has been the subject of a number of other research reports. Cantor Fitzgerald reiterated an “overweight” rating on shares […]
HC Wainwright reaffirmed their buy rating on shares of ALX Oncology (NASDAQ:ALXO – Free Report) in a research report report published on Friday,Benzinga reports. HC Wainwright currently has a $5.00 price target on the stock. ALXO has been the subject of a number of other research reports. Cantor Fitzgerald reiterated an “overweight” rating on shares […]
